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ABSTRACT, Over 100 serotypes of rhinoviruses, ODe of the primary causes of 
the common cold. co-circulate in the human population. This high diversity 
makes it effectively impossible to develop a vaccine, even for those at risk of 
complications due to asthma or cystic fibrosis. Is the high mutation rate of 
these viruses sufficient to explain this diversity? \Ve use parameters estimated 
from the literature to study whether immune interactions between different 
rhino\irus serotypes also play an important role in maintaining diversity. Our 
mathematical models indicate that high mutation rates alone may well be 
respop.sible rOT the obsel";ed le\'els of di\'ersity. However, careful studies of a 
few communities ha\'e found that some serotypes persist for many years, in 
conflict with the predictions of the simplest models, hinting that there might 
be more to the slOry than is yet known. 
1. Introduction 
Diversity is usually regarded as an ecological question and is rarely considered 
in the realm of virology ;1]. Howe\"er. the immense diversity of rhinoviruses, the 
most frequent cause of the common cold, makes development of treatments and a 
vaecine \"irtually impossible )5]. \Ye use mathemabcal and computer simulation 
models to attempt to understand the maintenance of this high diversity. 
There are currently 102 serotypes of the human rhinovirus (HRV) that co-
circulate in the human population, di..-ided into type A (with 76 serotypes), type 
B {25 serotype-5i. and a single type which clusters with enteroviruses [30]. HRV is 
a genus in the family PiCollwL'iridae and shares the characteristics of other genera 
v.ithin this family ie.g. enterovirus. poliO\·irus, foot and mouth disease virus, and 
hepatitis A virus l. These characteristics include a non-enveloped icosahedral capsid 
and a single-stranded positiYe-sense R..;."L-\ genome of approximately 7.2 kb. Viruses 
are spherical in shape with a diameter of 25-30 nm [8J. Within Picornaviridae, 
HRV is genetically most closely related to the enteroviruses [21J. The enteroviruses 
can tolerate a '\\-ider range of pH and therefore multiply mainly in the alimentary 
tract while HRV multiplies in the nasal epithelium [31J. HRV serotypes cause as 
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many as 40% of upper respiratory illnesses, or "common colds" [17J. They have 
also been associated with bacterial sinusitis and otitis media [8J, and appear in over 
80% of acute asthma episodes in children [14J. 
Once a sufficient dose, as small as 1-30 particles, has deposited itself in the 
nasal passages it is transported back to the adenoid area [9, 18]. Then the virus 
attaches to a receptor on the surface of the nasal cells. HRV-A serotypes attach to 
the Intercellular Adhesion Molecule-l (ICAf'd-l) receptor while serotypes in HRV-B 
attach to the low density lipoprotein receptor (LDLR) [6]. This attachment leads 
to the infection process. The incubation period is 8-12 hours with the peak of 
infection occurring in 36-72 hours [15]. 
The goal of this paper is to develop a model to explain the observed diversity 
of HRV using characteristics from its pathology and evolution. The maintenance of 
diversity may be explained by the high mutation rate of HRV, the cross-reactivity 
between serotypes, or immunodominance from previous infections. 
RN A viruses typically have high rates of mutation and can be thought of as 
a quasi-species [25]. It has been shown that the mutation rate for HRV is 0.67 
mutations per genome, or 10-4 per nucleotide per replication [10]. This high rate 
of mutation may lead to evolution of serotypes. In 1969 it was suggested that HRV-
51 had undergone sufficient variation in two to four years to produce a new serotype 
[32]. A recent experiment found that HRV-17 could quickly evolve to escape the 
antisera used to identify serotypes, while 15 other serotypes showed little or no such 
evolution [28]. 
Cross-reactivity between serotypes led to the proposal that groups of HRV share 
common epitopes. In 1975, Cooney et al. [7] analyzed the published literature and 
in combination with their ovm data found evidence for a strong relationship between 
serotypes. They found that a serotype will elicit a heterotypic antibody response 
from an average of 3.75 other serotypes. 
A rhinovirus in the human body presents a large number of epitopes to the 
immune system. The immune response focuses on only a few of the many potential 
epitopes, a process called immunodominance [12]. The sequence in which the host 
encounters antigenic variants influences the specifiCity of the immune response. This 
process was termed original antigenic sin [3]. For example, if the primary exposure 
in the host was with antigen A which elicited an immune response a, a secondary 
exposure to a related antigen A' could stimulate the same immune response a. A 
rapid response from the memory B or T cells may keep the antigen density below 
a threshold required for stimulation of naive B or T cells [12]. Although there may 
be a better response to a particular antigen, the immune system does not respond 
with it because the invasion has been regulated by existing memory cells. 
A previous model by Pease [29] considered an evolutionary epidemic model in 
which a person would go from having immunity to a virus back to being susceptible 
after the virus had changed genetically, and hence immunologically. Andreasen 
et al. [4] developed an influenza model to consider partial cross-protection among 
strains. In the model, the immunity history of the host population was followed so 
that invading strains could be analyzed against it. This allowed for the existence 
of a multi-strain endemic equilibrium. Cross-immunity has been the focus of other 
papers as well [5, 13J. In particular, recent work has included cross-immunity, 
mutation, and demographic stochasticity in a study of the persistence and dynamics 
of a viral disease [1]. 
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Other groups have developed a mathematical model of immunodominance in 
HN-l infections [26, 27]. These models focus on competition for stimulation by 
e?itopes betw~en immune cell lineages, concluding that the most efficient predat~r 
(nnmune cellimeage) reduces the prey (epitopes) down to a level where less efficient 
predators cannot survive. Models of immunological interactions bet.ween different 
dengue virus serotypes allow modelers to identify the immunological distance at 
which serotypes can stably coexist [22J. 
Hubbell [20] developed a neutral theory for species richness and relative specie:> 
abundance. The theory is neutral because individual organisms do not differ in 
their demographic parameters, and there are no competitive interactions other than 
maintenance of constant population size. The theory proposes that only three pa-
rameters are needed to determine diversity: the fundamental biodiversity number 
(which includes metacommunity size and speciation rate), the probabilit; of immi-
gration, and the local community size. 
Our aim is to estimate the relevant parameter:> for HRV, and to test what effect::; 
cross-innnunity and immunodominance have on maintained diversity in comparison 
to the neutral case. As a test, we compare our model results with a detailed study of 
the small town of Tecumseh, Michigan [24], comparing the observed diversity ~nd 
serotype frequency during the two time periods covered by the study, and checking 
whether the overlap in serotypes between the two periods is realistic. 
2. The simulation 
Rhinovirus serotypes are placed on a d-dimensional hyper-torus, with periodic 
boundaries of length 2. Each serotype is represented by a single hypercube with 
sides of length one, creating space for 2d serotypes. The maximum distance be-
tween sera types is J(1, relative to the difference between serotypes. The difference 
between the most similar serotypes is roughly 10% nucleotide divergence [28], thus 
a dimension of d = 10 is consistent with the ma.ximum divergence of 34 - 41% 
observed [30]. This dimension leaves room for 210 = 1024 possible serotypes, an 
order of magnitude more than have been observed. 
Our model tracks the infectious and immune state of each individual in a pop-
ulation of size N. Hosts are born and die at equal and constant rates, set to give a 
mean lifespan of 70 years. Newborn hosts have no HRV immunity. Every time step 
(one day), infected hosts have a probability 1 of clearing the infection. A value of 
1= 0.1 is consistent with a mean infection duration of 10 days [24]. Upon recovery, 
these individuals gain immunity to the infecting serotype. 
Susceptible individuals contract the illness through contact with a single pool 
of viruses rather than direct contact with other individuals. Such contacts occur 
with a pr~bability Q. The pool of viruses is created by mixing a fraction 1 - 171. 
from infected individuals in the population and a fraction m of random viruses 
to represent immigration. We chose values of 171. = 0 and 171. = 0.01 to study 
the effects of immigration, assuming in the latter case that an individual re-ente~s 
the local area on about 1 % of days, or four times per year. The value of a IS 
adjusted until the disease prevalence matches a pre-determined targ~t based o~ a 
frequency of approximately 0.5 HRV infections per pe.rson ~er year .wl~h a duratlOn 
of 10 days [17]. If contact occurs, the potentially mfectmg s~ral~ l~ a mutated 
version of a strain chosen randomly from the pool. The mutatlOn IS m a random 
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direction in the d dimensional space with a magnitude of J1 times a standard log.-
normal distribution (with mean and yariance equal to 11. The \:ah:e of J.L is chosen 
so that a new serotype is generated after about 50 infections .32,. meaning that 
most mutations do not generate a new serotype. Given a mutation rate of 10-4 
per nucleotide per replication [10]' we thus assume 20 replications per infection to 
achieve the 10% sequence diyergence between serotypes. 
Successful infection occurs if the exposed indh'idual dops not have immunity 
from previous infections (Figure 1). Pre\ious infect ions pwyicic part ial immunity 
out to a distance of Xi, with the probability of infection being 
distance to nearest prior infe<'tion 
Probability of infection = --------=-------
~', 
The parameter Xi is varied in our simulations. but should take on \'alue5 slightly 
larger than 1 to correspond to the obserwd degree of cros~.;.-reacthity. Immunity is 
determined by distance without explicit regard to serotype. Cnsu('ce:;."ful infections 
are included in the exposed indi\;dual's immune history whpn immunodominance 
is off, and are not included when it is on. In the lattpr case. we Rs:mme that the 
successful response was based entirely on the existing epitopE'5. 
TABLE 1. Variables, parameters. and function:- in fhe simulation 
Parameters 
Symbol Meaning \ 'alne or values 
, 
N Population size of hosts 1000 - >3000 , i 
Prevalence of rhlnm.irus infection~ 
} 
p 1).02 .- 0.1 ! ~ 
d Dimension of genetic space I or 10 i 
! 
Xi Cross-immunity distance 0.0- 2.0 I J.l Standard de.,iation of mutation distance 0.06 I 
(j Birth rate of hosts per day 1. ,70· :365J i i 
I Recovery rate of hosts per day 0.1 ! 
i 
a Contact rate of hosts ",;th \'irus pool 
, 
Computed , , ~ , 
m Probability of immigration of infected host Oar 0.01 
; 
I 
3. Simulation results 
Ho,,: we~ do these parameter estimates (summarized in Table 1) predict the 
actual dIverSIty of ~R':? Fi.rst, we compare our results with the neutral theory [201. 
The fundamental blOdIversIty parameter e is the product f th b J - NT f 
'n£ d' d' ·d· a e num er - p.. 0 I ecte III IVI uals and tWIce the effective mutation rate v. or 
e = 2vpN = 2vJ. 





















FIGl'RE 1. The structure of the simulation. An individual who 
started with the infection marked with # (displayed in a two-
dimensional \'ersion of the serotype space) infects another individ-
ual by transmitting the mutated version indicated by a *. The new 
individual has pre\iously had the two colds at locations marked 
"ith the x·s. and has immunity (potentially only partial immunity) 
in the regions indicated by the dashed circles. The new infection 
lies outside these circles, and is thus successful. Because it has 
crossed one of the lines in the grid, it is designated as a new 
serotype. 
185 
The effective mutation rate v includes the effects of both mutation and migration. 
The diversity Dr is then 
J e 
Dv L e+j -1 
)=1 
1)-1 1 c::::; B --dx x=o e +x 
( 0+J-1) BIn e 
. (2VPN + pN - 1) 
2vpN In 2vpN 
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FIGURE 2. Comparison of neutral theory predictions with simu-
lated diversity for the ranges of parameter "alue,;: in Table 1 but 
with no cross-immunity (Xi = 0). To avoid disea>'E' die-out in the 
smaller populations, we used an unrealisticall~' high prevalence of 
10%. To match the actual number of infections carried by a person 
in their lifetime, we increased the birth and death rates by a factor 
of 7.0. a. With no immigration (m = 0). b. \Yirh n of infections 
from immigration (m = 0.01). 
This model assumes that all new mutants form new serotypes. and our estimated 
dimension of d = 10 creates 1024 serotypes. a factor of 10 more than have been 
observed co-circulating in the human population. 
We estimated a value of v = 0.016 from the simulations with m = 0 (fairly 
close to our target value of 0.02 based on requiring approximately 50 infections 
to create a new serotype). We used a value of v = 0.016 -'- m in the ca..."€S with 
m = 0.01 because new migrants are essentially certain to be of a new serotype. In 
each case, the neutral theory predicts the overall diwrsity quite well in the absence 
of cross-immunity (Figure 2). 
Cross-immunity generally increases diversity. For relatiwly large populations, 
the increase is maximized at an intermediate scale of cross-immunity (Xi = 0.75 
to 1.0) roughly consistent with the scale of a serotype (Figure :3). Thus, the ob-
served relatively limited cross-immunity between serotypes [7] may be at a level 
that maximizes the standing diversity of HRV. Contrary to our original hypothesis, 
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FIGt·RE :3. The effects of cross-immunity on diversity using the 
parameter" in Figure 2 and m = o. A cross-immunity distance 
of 2.0 eorre:"prmd:; to deriving partial cross-immunity to all cold 
serotypes from any infection. Bars which share the same label have 
serotype ricimesses that are statistically indistinguishable (Tukey's 
honestly :;ignificanr differencesi. 
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\\"e then te:,ted the model on a detailed data set from Tecumseh Michigan 
collectt:d duriug the periods from 1966-1971 and 1976-1981 [24]. In'this study: 
symptomatic indi\·iduab from the community were visited, and their infections 
sampled. identified and serot~-ped. There were 250 HRV samples taken during 
the first period and 19.! during the latter. At that time, only 89 serotypes had 
been identificd and fully 7:3 of these were identified at some point in the study. 
Our simuiatiOlb were designed to match the size of this community (roughly 8000 
people) with our other most reasonable guesses of parameter values. 'Ve randomly 
sampled infected indiyiduals during two 6 year periods offset by 10 years from each 
other to match the design of the study. 
The domina!lct'-din'~rsity plots match the data fairly closely, although the distri-
butions with m = 0.01 haye too man~- singletons (Figure 5). The observed diversity 
matches that :,een ill the Tecumseh study reasonably well, although the predicted 
dh-ersities are tOO large when immigration is induded at even a low level (Table 2). 
Howen,r. the tu;il(J\·er during this time is far too large (the overlap in the 
last row of Table :2,. In Tecumseh. most of the serotypes observed in the earlier 
samples reappeared in the iater samples. in sharp contrast to our simulation results. 
The authors of the Tecumseh :;tudy argue that nearly all possible serotypes had 
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o 
Immunodominance No immunodominance 
FIGURE 4. The lack of an effect of immunodominance using the 
parameters in Figure 2. 
TABLE 2. Simulated and measured HR\' serotype diversity and 
overlap: d = 10 
Xi =0, Xi = 0. I Xi = 1. .f, = l. 
, 
I i m = 0.01 )'le?~"ured m=O m = 0.01 I m = 0 I 
1966-71 45 88 73 ! lEi 62 
: 
1976-81 40 86 66 86 .5:3 
j 
overlap 12 
·5 J 13 
I 8 42 ! 
additional ones have been identified subsequently. at least 2 of which cro..."S-reaci 
strongly with serotypes already identified [23], indicating that perhaps the numbers 
have saturated. 
To test this hypothesis, we reran our simulation in seven dimensions, creating 
only 128 possible serotypes, much closer to the number of identified serotypes. 
Not surprisingly, we found a much larger proportion of overlap between the two 
sampling periods, more in line with the observed results (Table :3). 
We used logistic regression (19] to test whether abundance in the earlier time 
period predicts presence in the later period. We find a highly significant effect (p < 
0.001) with the actual data (after including the 16 absent serot:;pes "'ith abundance 
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FIGl"RE 5. The predicted dominance-diversity curves for Tecum-
seh by running the simulation with N = 8000 and a more realistic 
preyalence of 10 days of infection per year (solid lines) compared 
with the actual data (dashed lines). The abundance rank of each 
serotype is based on the total number of individuals observed with 
that serotype. The Tecumseh study serotyped 250 individuals from 
1966-1971. and we sampled the same number of individuals over 
the course of 6 years from the simulations. Parameter values are 
a. I, = 0 and TIl = O. b. Xi = 0 and m = 0.01, C. Xi = 1 and 
m = O. and d. Ii = 1 and TIl = 0.01. 
TABLE 3. Simulated and measured HRV serotype diversity and 
overla p: d = I 
Ii = O. .T; = O. Xi = 1, Xi = 1, 
: m =0 TIl = 0.01 m=O m = 0.01 Measured 
, 
1966-71 j 29 69 56 70 62 
1976-81 .50 57 55 70 53 







\Ve have found that a simple model ">1th realistic parameters does a fairly good 
job of estimating the standing diversity of HRY. In general, the neutral theory well 
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approximates the results of simulations, although our effective mutation rate v dif-
fered slightly from that estimated directly from the underlying process. Inclusion 
of competition through cross-immunity increases diversity by as much as 25%. For 
larger population sizes (5000 individuals in this study), maximum diversity is main-
tained when cross-immunity acts at an intermediate scale which roughly matches 
scale seen in nature. Immunodominance, which describes the immune response to 
failed infections, has no detectable effect on diversity. 
Using parameters based on the detailed Tecumseh study [24], we find a good 
quantitative fit to the number of serotypes present. However, we find that the 
turnover between serotypes is far too fast unless we restrict the number of possible 
serotypes. If only approximately 100 serotypes are viable, it would be extremely 
interesting to understand the constraints operating on the sites which determine 
serotype [16]. Even in this case, however, the simulations differ from the actual 
measurements in showing no relationship between abundance in the first census and 
presence in the later census. If the observed relationship were due to a much lower 
mutation rate than we assume, the observed diversity could not be maintained. 
Alternatively, the relationship could be due to heterogeneity among the serotypes, 
either in detect ability or in transmission. 
Our model deals with disease transmission in only the simplest way. We neglect 
age-dependence of prevalence and duration of infection [17], seasonality [14], and 
heterogeneity in contact rates. As noted above, we also neglect differences among 
serotypes in their overall parameters and in their unstudied effects on people of 
different ages or immune functions. We do not consider the fact that immunity 
may well last no more than a few years [8]' and neglect the possible importance of 
recombination [2]. 
More detailed study of these models needs to address the observed phylogenetic 
relationships among coexisting serotypes [30]. Most simply, the models could use 
the two types A and B as roughly independent replicates of the experiment. The 
simulation could be made more explicitly genetic, rather than taking place in an 
abstract serotype space, and the results could then be presented explicitly as phy-
logenetic trees. Comparison with related studies of influenza, which shows a very 
different pattern of replacement of strains through antigenic drift and antigenic 
shift, could be particularly useful [11]. 
Given the wealth of genetic and epidemiological data available on this wide-
spread and important class of viral infections, we believe that the common cold can 
provide new insights into the applicability of ecological theories, and that ecological 
theory can provide new insights into the transmission and evolution of the common 
cold. 
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